 Adaptive Biotechnologies Corporation NASDAQ:ADPT CEO Chad M. Robins sold 1,900 shares of the firms stock in a transaction that occurred on Tuesday, September 29th. The stock was sold at an average price of 50.18, for a total transaction of 95,342.00. Following the completion of the sale, the chief executive officer now owns 1,780,080 shares in ... 